Mitochondrial dysfunction in DDR-related cancer predisposition syndromes

Biochimica et Biophysica Acta - Reviews on Cancer

Volumn 1865, Issue 2, 2016, Pages 184-189

  Lyakhovich, Alex ^a,b,c   Graifer, Dmitry ^d   Stefanovie, Barbora ^a   Krejci, Lumir ^a,b  

^a MASARYK UNIVERSITY   (Czech Republic)

^b ST ANNE S UNIVERSITY HOSPITAL   (Czech Republic)

^c INSTITUTE OF MOLECULAR BIOLOGY AND BIOPHYSICS   (Russian Federation)

^d NOVOSIBIRSK STATE UNIVERSITY   (Russian Federation)

Author keywords

Autophagy; Cancer predisposition syndromes; DNA damage and repair; Mitochondrial dysfunction; Mitophagy; Oxidative stress; ROS

Indexed keywords

MITOCHONDRIAL DNA; REACTIVE OXYGEN METABOLITE;

CANCER SUSCEPTIBILITY; DISEASE ASSOCIATION; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DNA DAMAGE RESPONSE; GENE MUTATION; HUMAN; MITOPHAGY; NONHUMAN; NUCLEIC ACID STRUCTURE, METABOLISM AND FUNCTION; PRIORITY JOURNAL; REVIEW; AUTOPHAGY; DNA DAMAGE; MITOCHONDRION; NEOPLASMS; PHYSIOLOGY; SYNDROME;

AUTOPHAGY; DNA DAMAGE; HUMANS; MITOCHONDRIA; NEOPLASMS; SYNDROME;

EID: 84960888035     PISSN: 0304419X     EISSN: 18792561     Source Type: Journal    
DOI: 10.1016/j.bbcan.2016.02.006     Document Type: Review

References (60)

1. Sabharwal S.S., Schumacker P.T. Mitochondrial ROS in cancer: initiators, amplifiers or an Achilles' heel?. Nat. Rev. Cancer 2014, 14(11):709-721.
2. Ryan B.J., Hoek S., Fon E.A., Wade-Martins R. Mitochondrial dysfunction and mitophagy in Parkinson's: from familial to sporadic disease. Trends Biochem. Sci. 2015, 40(4):200-210.
3. Payne B.A., Chinnery P.F. Mitochondrial dysfunction in aging: much progress but many unresolved questions. Biochim. Biophys. Acta 2015, 1847(11):1347-1353.
4. Lane R.K., Hilsabeck T., Rea S.L. The role of mitochondrial dysfunction in age-related diseases. Biochim. Biophys. Acta 2015, 1847(11):1387-1400.
5. Moon H.E., Paek S.H. Mitochondrial dysfunction in Parkinson's disease. Exp. Neurobiol. 2015, 24(2):103-116.
6. Wallace D.C. Mitochondria and cancer. Nat. Rev. Cancer 2012, 12(10):685-696.
7. Senyilmaz D., Teleman A.A. Chicken or the egg: Warburg effect and mitochondrial dysfunction. F1000Prime Rep 2015, (7:41).
8. Cohen B.H., Gold D.R. Mitochondrial cytopathy in adults: what we know so far. Cleve. Clin. J. Med. 2001, 68(7):625-626.
9. Read C.Y., Calnan R.J. Mitochondrial disease: beyond etiology unknown. J. Pediatr. Nurs. 2000, 15(4):232-241.
10. Lightowlers R.N., Taylor R.W., Turnbull D.M. Mutations causing mitochondrial disease: what is new and what challenges remain?. Science 2015, 349(6255):1494-1499.
11. Valentin-Vega Y.A., Maclean K.H., Tait-Mulder J., Milasta S., Steeves M., Dorsey F.C., Cleveland J.L., Green D.R., Kastan M.B. Mitochondrial dysfunction in ataxia-telangiectasia. Blood 2012, 119(6):1490-1500.
12. Zhang J., Tripathi D.N., Jing J., Alexander A., Kim J., Powell R.T., Dere R., Tait-Mulder J., Lee J.H., Paull T.T., Pandita R.K., Charaka V.K., Pandita T.K., Kastan M.B., Walker C.L. ATM functions at the peroxisome to induce pexophagy in response to ROS. Nat. Cell Biol. 2015, 17(10):1259-1269.
13. García-Giménez J.L., Gimeno A., Gonzalez-Cabo P., Dasí F., Bolinches-Amorós A., Mollá B., Palau F., Pallardó F.V. Differential expression of PGC-1α and metabolic sensors suggest age-dependent induction of mitochondrial biogenesis in Friedreich ataxia fibroblasts. PLoS ONE 2011, 6(6).
14. Krenzlin H., Demuth I., Salewsky B., Wessendorf P., Weidele K., Bürkle A., Digweed M. DNA damage in Nijmegen Breakage Syndrome cells leads to PARP hyperactivation and increased oxidative stress. PLoS Genet. 2012, 8(3).
15. Meagher M., Lightowlers R.N. The role of TDP1 and APTX in mitochondrial DNA repair. Biochimie 2014, 100:121-124.
16. Dmitrieva N.I., Malide D., Burg M.B. Mre11 is expressed in mammalian mitochondria where it binds to mitochondrial DNA. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2011, 301(3):R632-R640.
17. Li B., Iglesias-Pedraz J.M., Chen L.Y., Yin F., Cadenas E., Reddy S., Comai L. Downregulation of the Werner syndrome protein induces a metabolic shift that compromises redox homeostasis and limits proliferation of cancer cells. Aging Cell 2014, 13(2):367-378.
18. Wang J.T., Xu X., Alontaga A.Y., Chen Y., Liu Y. Impaired p32 regulation caused by the lymphoma-prone RECQ4 mutation drives mitochondrial dysfunction. Cell Rep. 2014, 7(3):848-858.
19. Scheibye-Knudsen M., Ramamoorthy M., Sykora P., Maynard S., Lin P.C., Minor R.K., Wilson D.M., Cooper M., Spencer R., de Cabo R., Croteau D.L., Bohr V.A. Cockayne syndrome group B protein prevents the accumulation of damaged mitochondria by promoting mitochondrial autophagy. J. Exp. Med. 2012, 209(4):855-869.
20. Fang E.F., Scheibye-Knudsen M., Brace L.E., Kassahun H., SenGupta T., Nilsen H., Mitchell J.R., Croteau D.L., Bohr V.A. Defective mitophagy in XPA via PARP-1 hyperactivation and NAD(+)/SIRT1 reduction. Cell 2014, 157(4):882-896.
21. Parlanti E., Pietraforte D., Iorio E., Visentin S., De Nuccio C., Zijno A., D'Errico M., Simonelli V., Sanchez M., Fattibene P., Falchi M., Dogliotti E. An altered redox balance and increased genetic instability characterize primary fibroblasts derived from xerodermapigmentosum group A patients. Mutat. Res. 2015, 782:34-43.
22. Wang P.Y., Ma W., Park J.Y., Celi F.S., Arena R., Choi J.W., Ali Q.A., Tripodi D.J., Zhuang J., Lago C.U., Strong L.C., Talagala S.L., Balaban R.S., Kang J.G., Hwang P.M. Increased oxidative metabolism in the Li-Fraumeni syndrome. N. Engl. J. Med. 2013, 368(11):1027-1032.
23. Kumari U., Ya Jun W., Huat Bay B., Lyakhovich A. Evidence of mitochondrial dysfunction and impaired ROS detoxifying machinery in Fanconi anemia cells. Oncogene 2014, 33(2):165-172.
24. Pagano G., Shyamsunder P., Verma R.S., Lyakhovich A. Damaged mitochondria in Fanconi anemia - an isolated event or a general phenomenon?. Oncoscience 2014, 1(4):287-295.
25. Robinson C.M., Ohh M. The multifaceted von Hippel-Lindau tumour suppressor protein. FEBS Lett. 2014, 588(16):2704-2711.
26. Kai S., Tanaka T., Daijo H., Harada H., Kishimoto S., Suzuki K., Takabuchi S., Takenaga K., Fukuda K., Hirota K. Hydrogen sulfide inhibits hypoxia- but not anoxia-induced hypoxia-inducible factor 1 activation in a von Hippel-Lindau- and mitochondria-dependent manner. Antioxid. Redox Signal. 2012, 16(3):203-216.
27. Akbari M., Sykora P., Bohr V.A. Slow mitochondrial repair of 5'-AMP renders mtDNA susceptible to damage in APTX deficient cells. Sci. Rep. 2015, 5:12876.
28. Tadi S.K., Sebastian R., Dahal S., Babu R.K., Choudhary B., Raghavan S.C. Microhomology mediated end joining is the principal mediator of double-strand break repair during mitochondrial DNA lesions. Mol. Biol. Cell 2015, (pii: mbc.E15-05-0260).
29. So E.Y., Ouchi T. BRAT1 deficiency causes increased glucose metabolism and mitochondrial malfunction. BMC Cancer 2014, 14:548.
30. Feichtinger R.G., Sperl W., Bauer J.W., Kofler B. ExpDermatol. Mitochondrial Dysfunct. Negl. Compon. Skin Dis. 2014, 23(9):607-614.
31. Blackstone C., Chang C.R. Mitochondria unite to survive Nat. Cell Biol. 2011, 1(5):521-522.
32. Franz A., Kevei É., Hoppe T. Double-edged alliance: mitochondrial surveillance by the UPS and autophagy. Curr. Opin. Cell Biol. 2015, 37:18-27.
33. Helgason H., Rafnar T., Olafsdottir H.S., Jonasson J.G., Sigurdsson A., Stacey S.N., Jonasdottir A., Tryggvadottir L., Alexiusdottir K., Haraldsson A., le Roux L., Gudmundsson J., Johannsdottir H., Oddsson A., Gylfason A., Magnusson O.T., Masson G., Jonsson T., Skuladottir H., Gudbjartsson D.F., Thorsteinsdottir U., Sulem P., Stefansson K. Loss-of-function variants in ATM confer risk of gastric cancer. Nat. Genet. 2015, 47(8):906-910.
34. Roberts N.J., Jiao Y., Yu J., Kopelovich L., Petersen G.M., Bondy M.L., Gallinger S., Schwartz A.G., Syngal S., Cote M.L., Axilbund J., Schulick R., Ali S.Z., Eshleman J.R., Velculescu V.E., Goggins M., Vogelstein B., Papadopoulos N., Hruban R.H., Kinzler K.W., Klein A.P. ATM mutations in patients with hereditary pancreatic cancer. Cancer Discov. 2012, 2(1):41-46.
35. Awasthi P., Foiani M., Kumar A. ATM and ATR signaling at a glance. J. Cell Sci. 2015, 128(23):4255-4262.
36. Evans-Galea M.V., Lockhart P.J., Galea C.A., Hannan A.J., Delatycki M.B. Beyond loss of frataxin: the complex molecular pathology of Friedreich ataxia. Discov Med. 2014, 17(91):25-35.
37. Thierbach R., Drewes G., Fusser M., Voigt A., Kuhlow D., Blume U., Schulz T.J., Reiche C., Glatt H., Epe B., Steinberg P., Ristow M. The Friedreich's ataxia protein frataxin modulates DNA base excision repair in prokaryotes and mammals. Biochem. J. 2010, 432(1):165-172.
38. Guccini I., Serio D., Condò I., Rufini A., Tomassini B., Mangiola A., Maira G., Anile C., Fina D., Pallone F., Mongiardi M.P., Levi A., Ventura N., Testi R., Malisan F. Frataxin participates to the hypoxia-induced response in tumors. Cell Death Dis. 2011, 24(2):e123.
39. Bolinches-Amorós A., Mollá B., Pla-Martín D., Palau F., González-Cabo P. Mitochondrial dysfunction induced by frataxin deficiency is associated with cellular senescence and abnormal calcium metabolism. Front. Cell. Neurosci. 2014, 13(8):124.
40. Chrzanowska K.H., Gregorek H., Dembowska-Bagińska B., Kalina M.A., Digweed M. Nijmegen Breakage Syndrome (NBS). Orphanet J. Rare Dis. 2012, 7:13.
41. Turinetto V., Porcedda P., Minieri V., Orlando L., Lantelme E., Accomasso L., Amoroso A., De Marchi M., Zannini L., Delia D., C.Giachino A novel defect in mitochondrial p53 accumulation following DNA damage confers apoptosis resistance in Ataxia Telangiectasia and Nijmegen Breakage Syndrome T-cells. DNA Repair (Amst) 2010, 9(11):1200-1208.
42. Scheibye-Knudsen M., Scheibye-Alsing K., Canugovi C., Croteau D.L., Bohr V.A. A novel diagnostic tool reveals mitochondrial pathology in human diseases and aging. Aging (Albany NY) 2013, 5(3):192-208.
43. Lee J., Giordano S., Zhang J. Autophagy, mitochondria and oxidative stress: cross-talk and redox signaling. Biochem. J. 2012, 441(2):523-540.
44. Frank M., Duvezin-Caubet S., Koob S., Occhipinti A., Jagasia R., Petcherski A., Ruonala M.O., Priault M., Salin B., Reichert A.S. Mitophagy is triggered by mild oxidative stress in a mitochondrial fission dependent manner. Biochim. Biophys. Acta 2012, 1823(12):2297-2310.
45. Wallace D.C. Mitochondria and cancer. Nat. Rev. Cancer. 2012, 12:685-698.
46. Harris I.S., Treloar A.E., Inoue S., Sasaki M., Gorrini C., Lee K.C., Yung K.Y., Brenner D., Knobbe-Thomsen C.B., Cox M.A., Elia A., Berger T., Cescon D.W., Adeoye A., Brüstle A., Molyneux S.D., Mason J.M., Li W.Y., Yamamoto K., Wakeham A., Berman H.K., Khokha R., Done S.J., Kavanagh T.J., Lam C.W., Mak T.W. Glutathione and thioredoxin antioxidant pathways synergize to drive cancer initiation and progression. Cancer Cell 2015, 27(2):211-222.
47. Sayin V.I., Ibrahim M.X., Larsson E., Nilsson J.A., Lindahl P., Bergo M.O. Antioxidants accelerate lung cancer progression in mice. Sci. Transl. Med. 2014, 6(221). (221ra15).
48. Piskounova E., Agathocleous M., Murphy M.M., Hu Z., Huddlestun S.E., Zhao Z., Leitch A.M., Johnson T.M., DeBerardinis R.J., Morrison S.J. Oxidative stress inhibits distant metastasis by human melanoma cells. Nature 2015, 527(7577):186-189.
49. Tan A.S., Baty J.W., Dong L.F., Bezawork-Geleta A., Endaya B., Goodwin J., Bajzikova M., Kovarova J., Peterka M., Yan B., Pesdar E.A., Sobol M., Filimonenko A., Stuart S., Vondrusova M., Kluckova K., Sachaphibulkij K., Rohlena J., Hozak P., Truksa J., Eccles D., Haupt L.M., Griffiths L.R., Neuzil J., Berridge M.V. Mitochondrial genome acquisition restores respiratory function and tumorigenic potential of cancer cells without mitochondrial DNA. Cell Metab. 2015, 21(1):81-94.
50. Schubert R., Erker L., Barlow C., et al. Cancer chemoprevention by the antioxidant tempol in Atm-deficient mice. Hum. Mol. Genet. 2004, 13(16):1793-1802.
51. Pereira-Lopes S., Tur J., Calatayud-Subias J.A., Lloberas J., Stracker T.H., Celada A. NBS1 is required for macrophage homeostasis and functional activity in mice. Blood 2015, 126(22):2502-2510.
52. Bandy A., Davison A.J. Mitochondrial mutations may increase oxidative stress: implications for carcinogenesis and aging?. Free Radic. Biol. Med. 1990, 8:523-539.
53. Croteau D.L., Rossi M.L., Canugovi C., Tian J., Sykora P., Ramamoorthy M., Wang Z.M., Singh D.K., Akbari M., Kasiviswanathan R., Copeland W.C., Bohr V.A. RECQL4 localizes to mitochondria and preserves mitochondrial DNA integrity. Aging Cell 2012, 11(3):456-466.
54. Sharma N.K., Lebedeva M., Thomas T., Kovalenko O.A., Stumpf J.D., Shadel G.S., Santos J.H. Intrinsic mitochondrial DNA repair defects in ataxia telangiectasia. DNA Repair (Amst) 2014, 13:22-31.
55. Houshmand M., Kasraie S., EtemadAhari S., Moin M., Bahar M., Zamani A. Investigation of tRNA and ATPase 6/8 gene mutations in Iranian ataxia telangiectasia patients. Arch. Med. Sci. 2011, 7(3):523-527.
56. Liu J., Fang H., Chi Z., Wu Z., Wei D., Mo D., Niu K., Balajee A.S., Hei T.K., Nie L., Zhao Y. XPD localizes in mitochondria and protects the mitochondrial genome from oxidative DNA damage. Nucleic Acids Res. 2015, 43(11):5476-5488.
57. Takeuchi F., Harihara S., Nakamura K., Takubo K., Kanamori M., Goto M. The mitochondrial DNA A3243G mutation in Werner's syndrome. Exp. Gerontol. 2003, 38(3):339-342.
58. Kamenisch Y., Fousteri M., Knoch J., von Thaler A.K., Fehrenbacher B., Kato H., Becker T., Dolle M.E., Kuiper R., Majora M., Schaller M., van der Horst G.T., van Steeg H., Röcken M., Rapaport D., Krutmann J., Mullenders L.H., Berneburg M. Proteins of nucleotide and base excision repair pathways interact in mitochondria to protect from loss of subcutaneous fat, a hallmark of aging. J. Exp. Med. 2010, 207:379-390.
59. Rezvani H.R., Kim A.L., Rossignol R., Ali N., Daly M., Mahfouf W., Bellance N., Taïeb A., de Verneuil H., Mazurier F., Bickers D.R. XPC silencing in normal human keratinocytes triggers metabolic alterations that drive the formation of squamous cell carcinomas. J. Clin. Invest. 2011, 121(1):195-211.
60. D'Souza A.D., Parish I.A., Krause D.S., Kaech S.M., Shadel G.S. Reducing mitochondrial ROS improves disease-related pathology in a mouse model of ataxia-telangiectasia. Mol. Ther. 2013, 21(1):42-48.